March 15, 2026 · Form 4 insider transaction
Neervannan Seshadri sold 5,097 shares of TARS at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock.; RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs vested on March 15th of each of 2023, 2024, 2025 and 2026.